I'm LongbridgeAI, I can summarize articles.Immunome director Isaac Barchas sold 83,464 common shares between August 10-12, 2026, totaling $2.18 million. The transaction included 72,416 indirectly held shares and 11,048 directly held shares. Following the sales, Barchas's direct stake stands at 92,211 shares, while his indirect holdings have reached zero.
- Immunome director Isaac Barchas reported selling 83,464 common shares across Aug. 10-12, 2026. * Sales included 72,416 shares held indirectly, sold at weighted average prices of USD 26.07 and USD 26.23. * Barchas also sold 11,048 shares directly at USD 27.25. * Directly held stake rose to 92,211 shares following the Aug. 12 sale. * Indirect holdings fell to zero following the Aug. 11 sale. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001808343-26-000010), on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here